This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Numerous health studies have shown the association between acute [1–5] and chronic [6–8] particulate matter (PM) exposures and the increase in mortality and morbidity risks in adults and children. In addition, growing evidences have shown that maternal exposure to PM during pregnancy might be associated with an impaired fetal development [9] and adverse birth outcomes [10], such as preterm birth and low birth weight [11] at term. The molecular mechanisms responsible for such effects are still mostly unclear, although studies have repeatedly evoked the role of oxidative stress and inflammation in mediating the effects of PM on human health [12].
Two of the main actors in the process of oxidative stress and inflammation are mitochondria and telomeres.
Mitochondria are cytoplasmic organelles which represent the major intracellular source and the preferred target of reactive oxygen species (ROS). Mitochondrial DNA copy number (mtDNAcn) correlates with the size and number of mitochondria within each cell [13] and is modulated by both endogenous and environmental factors [14]. PM exposure is a strong prooxidant stimulus that has been consistently associated with an mtDNAcn increase, as cells exposed to oxidative stress synthesize more copies of their mtDNA in order to compensate the damage. On the basis of these observations, alterations in mtDNAcn in various tissues, including whole blood, have emerged as a possible biomarker of mitochondrial dysfunction and risk factor for diverse cardiometabolic and neurodegenerative disorders as well as multiple cancers [15–17]. Notably, these diverse disorders have oxidative stress as a pathophysiological mechanism in common.
Increasing evidence that environmental exposure, such as smoking [18], benzene [19, 20], and ambient PM [21, 22], modifies mtDNAcn has begun to accumulate. Remarkably, a decreased placenta mtDNAcn was observed in relation to third trimester prenatal exposure to PM10 [23], and an altered cord blood mtDNAcn has been associated with adverse pregnancy outcomes, including an abnormal fetal growth [24].
Telomeres are located at the end of each chromosome and prevent DNA loss after each cell division in order to preserve the full genomic information [25]. Telomere length (TL) is strongly linked to biological age and is impacted by oxidative stress [26]. PM exposure has been associated with a modification in leukocyte TL, but this mainly concerns occupationally exposed subjects [27–29]; indeed, only limited evidence has been caused on pregnant women. Moreover, studies that have been conducted so far cover placenta or cord blood rather than maternal peripheral blood [30].
The aim of the present study is to determine the effects of exposure to PM2.5 and PM10 during the first trimester of pregnancy, on mtDNAcn and TL, in a sample of 199 healthy pregnant women recruited at the 11th week of pregnancy. We also evaluated the association among PM exposure, the abovementioned markers, and fetal growth parameters. Our hypothesis is that PM might increase maternal oxidative stress, accelerate telomere shortening, and finally impact on fetal growth.
2. Methods
2.1. Study Subjects
We recruited 199 healthy pregnant women at the “Clinica Mangiagalli”, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, in the period between June 2014 and October 2015. Women aged 18 to 51 years with singleton pregnancies who were attending prenatal healthcare clinics in the 11th week of pregnancy were eligible for this study. Exclusion criteria include a history of illicit drug use, diabetes, hypertension, or some other chronic health conditions. A detailed informed consent form was signed by all participants, and the study was approved by the ethic committee of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico. Information about demographics and lifestyle characteristics of the mother, such as smoking habits or alcohol consumption, was collected.
2.2. Fetal Ultrasound Measures and Birth Outcomes
Fetal measures were taken at the 11th week of pregnancy, as part of the prenatal screening test, when ultrasound fetal examination and drawing of blood (both for clinical assessment and for telomere/mtDNAcn measurements) were performed. During ultrasound examination, data about crown-rump length (CRL), nuchal translucency (NT), and fetal heart rate (FHR) were registered. Gestational age was calculated from the first day of the last menstrual period. At birth, we collected medical records of the newborns, obtaining data about gestational age at delivery, birth weight (BW), birth length (BL), and birth head circumference (BHC).
2.3. Exposure Assessment
Data on PM10 and PM2.5 were provided by Lombardy’s Regional Environmental Protection Agency (ARPA) which regularly collects daily concentration of both pollutants using fixed monitoring stations of the Air Quality Monitoring Network. Daily exposure was calculated by averaging daily concentration of PM2.5 and PM10 from the available monitoring stations covering the city of Milan.
We assigned to each study subject twelve exposure cumulative intervals to pollutants obtained as cumulative mean of each gestational age week calculated from the last menstrual period date. The mean of gestational age week intervals ranges from the first week of pregnancy (0–1 w) to the entire first trimester (0–12 w). To account for missing data for a specific monitor, we used the information on the same pollutant and monitor on other days of the same year plus measurements of the same pollutant and day on the other available monitors [31].
2.4. Blood Collection and DNA Extraction
Blood was collected in EDTA tubes and processed within 2 hr of phlebotomy. EDTA-treated blood was centrifuged at 1200 × g for 15 min at room temperature to separate the buffy coat fraction from platelet-free blood plasma. The buffy coat fraction was transferred in a Cryovial and immediately frozen at −80°C until DNA extraction.
DNA was extracted using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA) following the manufacturer’s instructions.
2.5. Telomere Length and mtDNAcn Measurement by Quantitative Real-Time PCR
TL and mtDNAcn were measured by using the real-time quantitative PCR method as described by Cawthon [32, 33] and Hou et al. [21].
These assays measure relative TL and relative mtDNAcn in DNA by determining, respectively, the ratio of telomere repeat copy number (T) and mitochondrial (mt) copy number to a single nuclear copy gene (S), which was the human (beta) globin (hbg). The T/S ratio and mt/S ratio are calculated in a given sample relatively to a reference pool DNA. The reference pool DNA was prepared from 50 DNA samples (1 μg DNA for each sample).
A fresh standard curve prepared from the pooled DNA, ranging from 30 ng/μl to 0.23 ng/μl (serial dilutions 1 : 2), was included in every “T,” “mt,” and “S” PCR runs. For each sample, 9 ng of DNA was used as a template, and the reaction was run in triplicate. A high-precision MICROLAB STARlet Robot (Hamilton Life Science Robotics, Bonaduz AG, Switzerland) was used for transferring a volume of 7 μl reaction mix and 3 μl DNA (3 ng/μl) in a 384-well format plate. All PCRs were performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems). Primers were previously reported [21, 32, 33]. At the end of each real-time PCR reaction, a melting curve was added in order to confirm the amplification specificity and the absence of primer dimers. The average of the three T and three mt measurements was divided by the average of the three S measurements to, respectively, calculate the T/S or the mt/S ratio for each sample.
2.6. Statistical Analysis
Summary statistics for mother and newborn characteristics are presented as mean ± SD or frequency and percentage. The correlation between mtDNAcn and TL was examined. To investigate whether PM exposure was associated with mtDNAcn or TL, we evaluated the associations between daily PM concentrations in the first trimester of pregnancy (as gestational age week intervals) and mtDNAcn or TL. A univariate exploratory analysis was performed to select potential covariates associated with each outcome (i.e., age, sex, BMI, smoking habits, ethnicity, ovulation induction, parity, previous miscarriage, drug assumption before and during pregnancy, seasonal infections measured by the number of seasonal flu cases in Lombardy region (https://www.cirinet.it/jm/sorveglianza-virologica/stagioni-precedenti/clinico-epidemiologica.html), season, day and week of enrolment, humidity, temperature, and apparent temperature). The selection of the most appropriate model structures was based on the minimization of the Akaike information criterion (AIC). The best model selected was adjusted for age, smoking habits (never, past, or current smokers), season, maternal age, BMI (<25 kg/m2, BMI ≥ 25 kg/m2), and gestational week at examination. Dependent variables were log-transformed to achieve normality of models’ residuals. Estimated effects are reported as geometric mean ratio (GMR) and 95% confidence intervals (CI) associated with an increase of 10 μg/m3 in each pollutant. We used separate models to estimate the effects of PM2.5 and PM10 on each outcome.
We subsequently evaluated the association between mtDNAcn/TL and both fetal growth measures (FHR and CRL). All models were adjusted for the above-mentioned selected covariates.
We performed causal mediation analysis to identify potential pathways that could explain the observed associations between PM exposure and fetal growth. This approach examines how a third intermediate variable, i.e., the mediator, is related to the observed exposure-outcome relationship. In our study, we studied the potential mediator role of mtDNAcn in the association between PM and FHR (Supplementary Figure 2). For this analysis, we selected PM10 of the mean of the first 5 weeks of gestation (PM10, 0-5w) as it was the exposure associated with both FHR and mtDNAcn. To apply mediation models, three criteria must be satisfied. First, there must be a statistically significant association between exposure (PM10) and outcome (FHR). Second, the exposure (PM10) must have an effect on mediator (mtDNAcn), and third, the mediator must be associated with the outcome (FHR) when exposure is controlled (after adjusting for mtDNAcn). Unfortunately, in our study, the latter condition was not fulfilled; accordingly, we could not calculate a significant indirect effect (Supplementary Table 1).
In addition, we investigated (i) the association between PM and crown-rump length (CRL) by a multivariable regression model adjusted for smoking habits (never, past, or current smokers), season (winter, spring, summer, and autumn), maternal age, categorical BMI (<25 kg/m2, BMI ≥ 25 kg/m2), gestational week at examination, mtDNAcn, and interaction between categorical BMI and mtDNAcn and (ii) the association between PM and fetal hearth rate (FHR) by a multivariable regression model adjusted for smoking habits, season, maternal age, categorical BMI, gestational week at examination, TL, and interaction between categorical BMI and TL. Complete models were graphically explored only for the models showing the larger effects of PM on each fetal outcome. Due to a high number of comparisons, we took into account a correction for multiple comparisons based on the false discovery rate (FDR) control. A threshold of 0.05 was applied on FDR
3. Results
Table 1 shows the characteristics of the study population. Most women were nonsmokers, with a mean age of 33 years and an average prepregnancy BMI of 22.5 kg/cm2. A total of 190 pregnancies ended in live births: 7 miscarriages were recorded and two mothers were lost to follow-up. Table 1 also reports newborn characteristics of the 190 live births, including ultrasound measurements at recruitment and size at birth.
Table 1
Description of study population.
| Mean ± SD or range and number | |
|---|---|
| Mother ( | |
| Age (years) | 33.0 (3.9) |
| Gestational age at examination (weeks) | 11.9 (0.5) |
| Prepregnancy BMI (kg/m2) | 22.5 (4.0) |
| BMI, categorical | |
| BMI < 25 kg/m2 | 155 (77.9) |
| BMI ≥ 25 kg/m2 | 44 (22.1) |
| Self-reported smoking status | |
| Never smoker | 151 (75.9) |
| Past smoker | 30 (15.1) |
| Current smoker | 18 (9.1) |
| Parity | |
| 0 | 121 (60.8) |
| 1 | 67 (33.7) |
| 2 | 10 (5.0) |
| 3 | 1 (0.5) |
| Season of enrolment | |
| Autumn | 63 (31.7) |
| Winter | 41 (20.6) |
| Spring | 41 (20.6) |
| Summer | 54 (27.1) |
| Newborn ( | |
| Sex | |
| Male | 108 (56.8) |
| Female | 82 (43.2) |
| Gestational age at delivery (weeks) | 38.8 (1.4) |
| Birth weight (g) | 3272.9 (477.9) |
| Birth length (cm) | 49.9 (2.0) |
| Birth head circumference (cm) | 34.2 (1.5) |
| Crown-rump length (CRL) (mm) | 62.2 (6.9) |
| Nuchal translucency (NT) (cm) | 1.9 (0.4) |
| Fetal heart rate (FHR) (bpm) | 160.4 (6.1) |
As shown in supplementary Figure 1, the mean levels of ambient PM10 and PM2.5 measured in Milan the days before the examinations (0–12-week means) ranged from 10 to 90 μg/m3 and from 7 to 69 μg/m3, respectively.
We examined TL and mtDNAcn in DNA extracted from maternal whole blood sample of study subjects; as expected, age was inversely related to TL, even if not significantly (
Considering the association between PM exposure and mtDNAcn, we observed in all the gestational age intervals examined a PM-related increase in mtDNAcn for PM10 exposure, after adjusting for age, BMI, smoking habit, season, and gestational age at the examination (Figure 2(a)). The effect was maximum for the average of the first 5 weeks of pregnancy (adjusted GMR = 1.14; 95% CI: 1.08, 1.20;
On the contrary, we observed a negative and significant effect of the 12-week mean PM10 on TL (adjusted GMR = 0.94; 95% CI: 0.88, 0.99;
We further investigated the possible association between PM exposure and fetal outcomes (i.e., fetal heart rate, crown-lump length, and nuchal translucency) measured by ultrasound at the time of enrolment. PM10 was associated with an increased FHR from the gestational age week interval 0–2 (Figure 3(a)), ranging from an adjusted estimate of 1.16 in weeks 0–2 to an adjusted estimate of 1.61 in weeks 0–5. A similar trend was observed for PM2.5 exposure (Figure 3(b)). In addition, CRL was positively associated only with PM2.5 exposure (Figures 3(c) and 3(d)).
[figure omitted; refer to PDF]We investigated whether mtDNAcn could represent a mediator of the association between PM and FHR (Supplementary Figure 2). However, as we tried to formally investigate this possibility, we found that our data did not fulfill the necessary and sufficient conditions to establish mediation (Supplementary Table 1). This finding let us infer that mtDNAcn is not the mediator of the association.
No association was found between mtDNAcn and fetal outcomes (Supplementary Table 2). Nevertheless, when the interaction between mtDNA and CRL was taken into account, we observed a strong modifying effect of maternal BMI in modulating association between mtDNAcn and CRL. In Figure 4, we reported the beta estimates of each variable included as covariate in the multivariable linear regression model investigating the association between mtDNAcn and CRL. An interaction test formally performed to assess effect modification between BMI and mtDNAcn was statistically significant (
When we applied the same approach to investigate the determinants of FHR and possible interactions among variables (Supplementary Figure 3), the association of the TL with FHR was not significant, and the interaction test performed to assess effect modification between BMI and TL was not statistically significant (
No associations were observed either with TL and mtDNAcn or with nuchal translucency (NT) (data not shown).
The analysis of the association with the first trimester PM10 exposure on birth weight, applying a model adjusted for maternal age, smoke, season, maternal BMI, gestational age, mtDNAcn, and TL, showed a negative association for different time windows that reached significance at weeks 0–8 (adjusted estimate = −0.99; 95% CI: −194, −3.88;
4. Discussion
The main goal of the present study was to examine whether exposure to particulate matter (PM10 and PM2.5) experienced from the mother in the first trimester of pregnancy was associated with oxidative stress (estimated as mtDNAcn) and maternal TL. We also examined whether maternal mtDNAcn and TL were associated with fetal growth outcomes measured at the end of the first trimester of pregnancy (FHR, CRL, and NT) and at delivery (birth weight, length, and head circumference). The possible modifying effect of prepregnancy maternal BMI was evaluated.
PM10 exposure, considered in different week windows of the first pregnancy trimester, was associated with an increased maternal mtDNAcn and a reduced TL. As regards ultrasound fetal outcomes, both FHR and CRL were positively associated with PM2.5, whereas only the association with FHR was confirmed when examining PM10 exposure. PM10 was also associated with a reduced birth weight.
Our findings let us infer that mtDNAcn is not the mediator of the association between PM and FHR as our data did not fulfill the necessary and sufficient conditions to establish mediation. We therefore speculate that probably two independent pathways linked to PM exposure exist.
In addition, when we examined the possible modifying role of BMI, we found a negative relationship between mtDNAcn and fetal CRL only in overweight women, whereas normal-weight women exhibited a positive, albeit nonsignificant, association.
Pregnancy is a physiological condition characterized by an increased susceptibility to oxidative stress and inflammation. Placenta, in particular, has a central role in this context, as the high placental mitochondrial activity gives rise to an increased ROS production [34]. Ideally, this increased concentration of ROS should be balanced by an increase in antioxidant compounds and enzymes [35]. Increased mtDNAcn has been associated with adverse pregnancy outcomes, such as low and high birth weight [24], placental abruption [36], and preeclampsia [37].
PM exposure has been previously linked to an increased oxidative stress in occupational [21] and general environment settings [22, 38] as well as to a modification in TL [27, 29, 39]. In pregnant women, PM exposure has been also associated with a modification of oxidative stress measured in the placenta and in the cord blood at delivery [30, 40]. Most of the previous investigations examined placental mtDNAcn in relationship to PM exposure experienced during the last period of pregnancy and showed increased oxidative stress and TL shortening [23].
To the best of our knowledge, this is the first investigation focusing on oxidative stress measured in maternal blood collected at the end of the first trimester of pregnancy. Our findings confirm the relationship between PM exposure and both increased mtDNAcn as marker of oxidative stress and TL shortening. Interestingly, examining the possible correlation between TL and mtDNAcn, we found a correlation coefficient very similar to the ones previously reported in different experimental settings, such as elderly women [41] and in a female subgroup of the EPIC cohort [42].
Quite surprisingly, fetuses, whose mothers had an increased exposure, had a faster heart rate and higher CRL (measured at the 11th week of pregnancy), whereas in literature, PM exposure has been mostly related to smaller fetuses measured in more advanced stages of pregnancy. One possible explanation of this unexpected result could be speculative: at an early gestational age PM exposure might act with a selection mechanism that lead only stronger fetuses to survive.
Although alterations of fetal heart rate have been considered a symptom of fetal distress, the very large majority of studies investigated FHR at the third trimester of pregnancy. Thus, the meaning of the association we found between PM exposure and FHR is difficult to interpret and should be further investigated.
The negative effect of PM on weight at birth is instead coherent with current literature [43–45].
An additional comment regards the general lack of association with PM2.5, whereas we observe an effect associated with PM10 exposure. This finding is somehow surprising but it must be interpreted taking into account two factors. First, PM10 dataset available for the Lombardy region in the study period was more complete, and it was characterized by a better spatial resolution; thus, this allows a better estimate of exposure levels. Second, in the study area, PM10 is mainly constituted by fine particles, and PM2.5 represents 58–94% of PM10 [46].
The present study must be interpreted taking into account both strength and limitations. First, although the study population is not very large compared to other studies conducted on pregnant women, we collected very detailed information about possible confounding factors, and we were able to consider them in statistical analyses. Moreover, all study participants were recruited in the same hospital, and ultrasound measurements were performed by gynecologists after a standardized training program, using the same instrumentation.
A limitation of the study is given by the possible inaccuracy in estimating gestational age. Gestational age was calculated from the first day of the last menstrual period, and, indeed, this measurement is affected by menstrual irregularities. However, the possible measurement error is supposed to be randomly distributed, thus not affecting the relationship with PM exposure. On the contrary, the possible use of ultrasound measures to correct gestational age might have led to a systematic error due to the possible effect of PM exposure on fetal size. Finally, fetal ultrasound has a great deal of measurement error, and therefore, measurement error might drive the observed results, although such error should cause nondifferential exposure misclassification, and it seems unlikely to be driving the results.
The inclusion criteria of this study were very strict, as we enrolled only healthy women, with no comorbidities.
This choice has the advantage of examining a homogenous population and of limiting any possible confounders, although it prevents from the evaluation on particularly susceptibility conditions such as diabetes or hypertension.
Although the sample size of our study is limited, we were able to assess significant associations between PM and fetal growth and between PM and mtDNAcn/LT; however, we were not able to confirm a mediation role of mtDNAcn. Further studies performed on a larger population might help to elucidate the link between PM, mtDNAcn/LT, and fetal growth. In conclusion, in the present work, PM exposure was associated with an increased oxidative stress and a reduced TL measured in maternal blood at the end of the first trimester of pregnancy. The PM exposure experienced during the first trimester was also associated with CRL, FHR, and birth weight. As abnormalities of growth in utero has been associated with postnatal childhood and adulthood onset diseases, since PM is a widespread pollutant relevant to the large majority of the human population and obesity is a rising risk factor, our results, if confirmed in a larger population, might represent an important contribution towards the development of more targeted public health strategies.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
[1] J. Schwartz, A. Marcus, "Mortality and air pollution j London: a time series analysis," American Journal of Epidemiology, vol. 131 no. 1, pp. 185-194, DOI: 10.1093/oxfordjournals.aje.a115473, 1990.
[2] J. Schwartz, D. W. Dockery, "Increased mortality in Philadelphia associated with daily air pollution concentrations," The American Review of Respiratory Disease, vol. 145 no. 3, pp. 600-604, DOI: 10.1164/ajrccm/145.3.600, 1992.
[3] K. Katsouyanni, G. Touloumi, C. Spix, J. Schwartz, F. Balducci, S. Medina, G. Rossi, B. Wojtyniak, J. Sunyer, L. Bacharova, J. P. Schouten, A. Ponka, H. R. Anderson, "Short term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: results from time series data from the APHEA project," BMJ, vol. 314 no. 7095, article 1658,DOI: 10.1136/bmj.314.7095.1658, 1997.
[4] K. Katsouyanni, G. Touloumi, E. Samoli, A. Gryparis, A. le Tertre, Y. Monopolis, G. Rossi, D. Zmirou, F. Ballester, A. Boumghar, H. R. Anderson, B. Wojtyniak, A. Paldy, R. Braunstein, J. Pekkanen, C. Schindler, J. Schwartz, "Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project," Epidemiology, vol. 12 no. 5, pp. 521-531, DOI: 10.1097/00001648-200109000-00011, 2001.
[5] P. L. Kinney, H. Ozkaynak, "Associations of daily mortality and air pollution in Los Angeles County," Environmental Research, vol. 54 no. 2, pp. 99-120, DOI: 10.1016/S0013-9351(05)80094-5, 1991.
[6] D. W. Dockery, C. A. Pope, X. Xu, J. D. Spengler, J. H. Ware, M. E. Fay, B. G. Ferris, F. E. Speizer, "An association between air pollution and mortality in six U.S. cities," The New England Journal of Medicine, vol. 329 no. 24, pp. 1753-1759, DOI: 10.1056/NEJM199312093292401, 1993.
[7] C. A. Pope, M. J. Thun, M. M. Namboodiri, D. W. Dockery, J. S. Evans, F. E. Speizer, C. W. Heath, "Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults," American Journal of Respiratory and Critical Care Medicine, vol. 151, 3, Part 1, pp. 669-674, DOI: 10.1164/ajrccm/151.3_Pt_1.669, 1995.
[8] C. A. Pope, R. T. Burnett, G. D. Thurston, M. J. Thun, E. E. Calle, D. Krewski, J. J. Godleski, "Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease," Circulation, vol. 109 no. 1, pp. 71-77, DOI: 10.1161/01.CIR.0000108927.80044.7F, 2004.
[9] I. Korten, K. Ramsey, P. Latzin, "Air pollution during pregnancy and lung development in the child," Paediatric Respiratory Reviews, vol. 21, pp. 38-46, DOI: 10.1016/j.prrv.2016.08.008, 2017.
[10] D. K. Lamichhane, J. H. Leem, J. Y. Lee, H. C. Kim, "A meta-analysis of exposure to particulate matter and adverse birth outcomes," Environmental Health and Toxicology, vol. 30, article e2015011,DOI: 10.5620/eht.e2015011, 2015.
[11] X. Li, S. Huang, A. Jiao, X. Yang, J. Yun, Y. Wang, X. Xue, Y. Chu, F. Liu, Y. Liu, M. Ren, X. Chen, N. Li, Y. Lu, Z. Mao, L. Tian, H. Xiang, "Association between ambient fine particulate matter and preterm birth or term low birth weight: an updated systematic review and meta-analysis," Environmental Pollution, vol. 227, pp. 596-605, DOI: 10.1016/j.envpol.2017.03.055, 2017.
[12] R. D. Brook, S. Rajagopalan, C. A. Pope, J. R. Brook, A. Bhatnagar, A. V. Diez-Roux, F. Holguin, Y. Hong, R. V. Luepker, M. A. Mittleman, A. Peters, D. Siscovick, S. C. Smith, L. Whitsel, J. D. Kaufman, "Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association," Circulation, vol. 121 no. 21, pp. 2331-2378, DOI: 10.1161/CIR.0b013e3181dbece1, 2010.
[13] H. C. Lee, Y. H. Wei, "Mitochondrial role in life and death of the cell," Journal of Biomedical Science, vol. 7 no. 1,DOI: 10.1007/BF02255913, 2000.
[14] G. S. Shadel, "Expression and maintenance of mitochondrial DNA: new insights into human disease pathology," The American Journal of Pathology, vol. 172 no. 6, pp. 1445-1456, DOI: 10.2353/ajpath.2008.071163, 2008.
[15] R. Stark, M. Roden, "ESCI Award 2006. Mitochondrial function and endocrine diseases," European Journal of Clinical Investigation, vol. 37 no. 4, pp. 236-248, DOI: 10.1111/j.1365-2362.2007.01773.x, 2007.
[16] P. Ježek, L. Plecitá-Hlavatá, K. Smolková, R. Rossignol, "Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development," The International Journal of Biochemistry & Cell Biology, vol. 42 no. 5, pp. 604-622, DOI: 10.1016/j.biocel.2009.11.008, 2010.
[17] A. Pyle, H. Anugrha, M. Kurzawa-Akanbi, A. Yarnall, D. Burn, G. Hudson, "Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease," Neurobiology of Aging, vol. 38, pp. 216.e7-216.e10, DOI: 10.1016/j.neurobiolaging.2015.10.033, 2016.
[18] N. Bouhours-Nouet, P. May-Panloup, R. Coutant, F. B. de Casson, P. Descamps, O. Douay, P. Reynier, P. Ritz, Y. Malthièry, G. Simard, "Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placenta," American Journal of Physiology. Endocrinology and Metabolism, vol. 288 no. 1, pp. E171-E177, DOI: 10.1152/ajpendo.00260.2003, 2005.
[19] M. Carugno, A. C. Pesatori, L. Dioni, M. Hoxha, V. Bollati, B. Albetti, H. M. Byun, M. Bonzini, S. Fustinoni, P. Cocco, G. Satta, M. Zucca, D. F. Merlo, M. Cipolla, P. A. Bertazzi, A. Baccarelli, "Increased mitochondrial DNA copy number in occupations associated with low-dose benzene exposure," Environmental Health Perspectives, vol. 120 no. 2, pp. 210-215, DOI: 10.1289/ehp.1103979, 2012.
[20] M. Shen, L. Zhang, M. R. Bonner, C. S. Liu, G. Li, R. Vermeulen, M. Dosemeci, S. Yin, Q. Lan, "Association between mitochondrial DNA copy number, blood cell counts, and occupational benzene exposure," Environmental and Molecular Mutagenesis, vol. 49 no. 6, pp. 453-457, DOI: 10.1002/em.20402, 2008.
[21] L. Hou, Z. Z. Zhu, X. Zhang, F. Nordio, M. Bonzini, J. Schwartz, M. Hoxha, L. Dioni, B. Marinelli, V. Pegoraro, P. Apostoli, P. A. Bertazzi, A. Baccarelli, "Airborne particulate matter and mitochondrial damage: a cross-sectional study," Environmental Health, vol. 9 no. 1,DOI: 10.1186/1476-069X-9-48, 2010.
[22] L. Hou, X. Zhang, L. Dioni, F. Barretta, C. Dou, Y. Zheng, M. Hoxha, P. A. Bertazzi, J. Schwartz, S. Wu, S. Wang, A. A. Baccarelli, "Inhalable particulate matter and mitochondrial DNA copy number in highly exposed individuals in Beijing, China: a repeated-measure study," Particle and Fibre Toxicology, vol. 10 no. 1,DOI: 10.1186/1743-8977-10-17, 2013.
[23] B. G. Janssen, E. Munters, N. Pieters, K. Smeets, B. Cox, A. Cuypers, F. Fierens, J. Penders, J. Vangronsveld, W. Gyselaers, T. S. Nawrot, "Placental mitochondrial DNA content and particulate air pollution during in utero life," Environmental Health Perspectives, vol. 120 no. 9, pp. 1346-1352, DOI: 10.1289/ehp.1104458, 2012.
[24] C. Gemma, S. Sookoian, J. Alvariñas, S. I. García, L. Quintana, D. Kanevsky, C. D. González, C. J. Pirola, "Mitochondrial DNA depletion in small- and large-for-gestational-age newborns," Obesity, vol. 14 no. 12, pp. 2193-2199, DOI: 10.1038/oby.2006.257, 2006.
[25] M. A. Shammas, "Telomeres, lifestyle, cancer, and aging," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14 no. 1, pp. 28-34, DOI: 10.1097/MCO.0b013e32834121b1, 2011.
[26] M. A. Babizhayev, E. L. Savel’yeva, S. N. Moskvina, Y. E. Yegorov, "Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior," American Journal of Therapeutics, vol. 18 no. 6, pp. e209-e226, DOI: 10.1097/MJT.0b013e3181cf8ebb, 2011.
[27] L. Dioni, M. Hoxha, F. Nordio, M. Bonzini, L. Tarantini, B. Albetti, A. Savarese, J. Schwartz, P. A. Bertazzi, P. Apostoli, L. Hou, A. Baccarelli, "Effects of short-term exposure to inhalable particulate matter on telomere length, telomerase expression, and telomerase methylation in steel workers," Environmental Health Perspectives, vol. 119 no. 5, pp. 622-627, DOI: 10.1289/ehp.1002486, 2011.
[28] S. Pavanello, A. C. Pesatori, L. Dioni, M. Hoxha, V. Bollati, E. Siwinska, D. Mielzynska, C. Bolognesi, P. A. Bertazzi, A. Baccarelli, "Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons," Carcinogenesis, vol. 31 no. 2, pp. 216-221, DOI: 10.1093/carcin/bgp278, 2010.
[29] L. Hou, S. Wang, C. Dou, X. Zhang, Y. Yu, Y. Zheng, U. Avula, M. Hoxha, A. Díaz, J. McCracken, F. Barretta, B. Marinelli, P. A. Bertazzi, J. Schwartz, A. A. Baccarelli, "Air pollution exposure and telomere length in highly exposed subjects in Beijing, China: a repeated-measure study," Environment International, vol. 48, pp. 71-77, DOI: 10.1016/j.envint.2012.06.020, 2012.
[30] G. Desai, L. Chu, Y. Guo, A. A. Myneni, L. Mu, "Biomarkers used in studying air pollution exposure during pregnancy and perinatal outcomes: a review," Biomarkers, vol. 22 no. 6, pp. 489-501, DOI: 10.1080/1354750X.2017.1339294, 2017.
[31] P. Bellini, M. Baccini, A. Biggeri, B. Terracini, "The meta-analysis of the Italian studies on short-term effects of air pollution (MISA): old and new issues on the interpretation of the statistical evidences," Environmetrics, vol. 18 no. 3, pp. 219-229, DOI: 10.1002/env.836, 2007.
[32] R. M. Cawthon, "Telomere length measurement by a novel monochrome multiplex quantitative PCR method," Nucleic Acids Research, vol. 37 no. 3, article e21,DOI: 10.1093/nar/gkn1027, 2009.
[33] R. M. Cawthon, "Telomere measurement by quantitative PCR," Nucleic Acids Research, vol. 30 no. 10, article e47,DOI: 10.1093/nar/30.10.e47, 2002.
[34] L. Myatt, X. Cui, "Oxidative stress in the placenta," Histochemistry and Cell Biology, vol. 122 no. 4, pp. 369-382, DOI: 10.1007/s00418-004-0677-x, 2004.
[35] M. T. Coughlan, P. P. Vervaart, M. Permezel, H. M. Georgiou, G. E. Rice, "Altered placental oxidative stress status in gestational diabetes mellitus," Placenta, vol. 25 no. 1, pp. 78-84, DOI: 10.1016/S0143-4004(03)00183-8, 2004.
[36] C. Qiu, S. E. Sanchez, K. Hevner, D. A. Enquobahrie, M. A. Williams, "Placental mitochondrial DNA content and placental abruption: a pilot study," BMC Research Notes, vol. 8 no. 1,DOI: 10.1186/s13104-015-1340-4, 2015.
[37] C. Qiu, K. Hevner, D. A. Enquobahrie, M. A. Williams, "A case-control study of maternal blood mitochondrial DNA copy number and preeclampsia risk," International Journal of Molecular Epidemiology Genetics, vol. 3 no. 3, pp. 237-244, 2012.
[38] N. Pieters, B. G. Janssen, H. Dewitte, B. Cox, A. Cuypers, W. Lefebvre, K. Smeets, C. Vanpoucke, M. Plusquin, T. S. Nawrot, "Biomolecular markers within the core axis of aging and particulate air pollution exposure in the elderly: a cross-sectional study," Environmental Health Perspectives, vol. 124 no. 7, pp. 943-950, DOI: 10.1289/ehp.1509728, 2016.
[39] M. Hoxha, L. Dioni, M. Bonzini, A. C. Pesatori, S. Fustinoni, D. Cavallo, M. Carugno, B. Albetti, B. Marinelli, J. Schwartz, P. A. Bertazzi, A. Baccarelli, "Association between leukocyte telomere shortening and exposure to traffic pollution: a cross-sectional study on traffic officers and indoor office workers," Environmental Health, vol. 8 no. 1,DOI: 10.1186/1476-069X-8-41, 2009.
[40] M. J. Rosa, A. C. Just, M. S. Guerra, I. Kloog, H. H. L. Hsu, K. J. Brennan, A. M. García, B. Coull, R. J. Wright, M. M. Téllez Rojo, A. A. Baccarelli, R. O. Wright, "Identifying sensitive windows for prenatal particulate air pollution exposure and mitochondrial DNA content in cord blood," Environment International, vol. 98, pp. 198-203, DOI: 10.1016/j.envint.2016.11.007, 2017.
[41] J. H. Kim, H. K. Kim, J. H. Ko, H. Bang, D. C. Lee, "The relationship between leukocyte mitochondrial DNA copy number and telomere length in community-dwelling elderly women," PLoS One, vol. 8 no. 6, article e67227,DOI: 10.1371/journal.pone.0067227, 2013.
[42] D. Campa, M. Barrdahl, A. Santoro, G. Severi, L. Baglietto, H. Omichessan, R. Tumino, H. B.(a.). Bueno-de-Mesquita, P. H. Peeters, E. Weiderpass, M. D. Chirlaque, M. Rodríguez-Barranco, A. Agudo, M. Gunter, L. Dossus, V. Krogh, G. Matullo, A. Trichopoulou, R. C. Travis, F. Canzian, R. Kaaks, "Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study," Breast Cancer Research, vol. 20 no. 1,DOI: 10.1186/s13058-018-0955-5, 2018.
[43] D. K. Lamichhane, J. Ryu, J. H. Leem, M. Ha, Y. C. Hong, H. Park, Y. Kim, D. Y. Jung, J. Y. Lee, H. C. Kim, E. H. Ha, "Air pollution exposure during pregnancy and ultrasound and birth measures of fetal growth: a prospective cohort study in Korea," Science of The Total Environment, vol. 619-620, pp. 834-841, DOI: 10.1016/j.scitotenv.2017.11.058, 2018.
[44] E. H. van den Hooven, F. H. Pierik, Y. de Kluizenaar, S. P. Willemsen, A. Hofman, S. W. van Ratingen, P. Y. J. Zandveld, J. P. Mackenbach, E. A. P. Steegers, H. M. E. Miedema, V. W. V. Jaddoe, "Air pollution exposure during pregnancy, ultrasound measures of fetal growth, and adverse birth outcomes: a prospective cohort study," Environmental Health Perspectives, vol. 120 no. 1, pp. 150-156, DOI: 10.1289/ehp.1003316, 2012.
[45] P. Dadvand, J. Parker, M. L. Bell, M. Bonzini, M. Brauer, L. A. Darrow, U. Gehring, S. V. Glinianaia, N. Gouveia, E. H. Ha, J. H. Leem, E. H. van den Hooven, B. Jalaludin, B. M. Jesdale, J. Lepeule, R. Morello-Frosch, G. G. Morgan, A. C. Pesatori, F. H. Pierik, T. Pless-Mulloli, D. Q. Rich, S. Sathyanarayana, J. Seo, R. Slama, M. Strickland, L. Tamburic, D. Wartenberg, M. J. Nieuwenhuijsen, T. J. Woodruff, "Maternal exposure to particulate air pollution and term birth weight: a multi-country evaluation of effect and heterogeneity," Environmental Health Perspectives, vol. 121 no. 3, pp. 267-373, DOI: 10.1289/ehp.1205575, 2013.
[46] A. Bigi, G. Ghermandi, "Long-term trend and variability of atmospheric PM 10 concentration in the Po Valley," Atmospheric Chemistry and Physics, vol. 14 no. 10, pp. 4895-4907, DOI: 10.5194/acp-14-4895-2014, 2014.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright © 2018 S. Iodice et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0/
Abstract
Growing evidences have shown that particulate matter (PM) exposures during pregnancy are associated with impaired fetal development and adverse birth outcomes, possibly as a result of an exaggerated systemic oxidative stress and inflammation. Telomere length (TL) is strongly linked to biological age and is impacted by oxidative stress. We hypothesized that PM exposure during different time windows in the first trimester of pregnancy influences both mitochondrial DNA copy number (mtDNAcn), an established biomarker for oxidative stress, and TL. Maternal blood TL and mtDNAcn were analysed in 199 healthy pregnant women recruited at the 11th week of pregnancy by quantitative polymerase chain reaction. We also examined whether maternal mtDNAcn and TL were associated with fetal growth outcomes measured at the end of the first trimester of pregnancy (fetal heart rate, FHR; crown-rump length, CRL; and nuchal translucency, NT) and at delivery (birth weight, length, head circumference). The possible modifying effect of prepregnancy maternal body mass index was evaluated. PM10 exposure during the first pregnancy trimester was associated with an increased maternal mtDNAcn and a reduced TL. As regards ultrasound fetal outcomes, both FHR and CRL were positively associated with PM2.5, whereas the association with FHR was confirmed only when examining PM10 exposure. PM10 was also associated with a reduced birth weight. While no association was found between mtDNAcn and CRL, we found a negative relationship between mtDNAcn and fetal CRL only in overweight women, whereas normal-weight women exhibited a positive, albeit nonsignificant, association. As abnormalities of growth in utero have been associated with postnatal childhood and adulthood onset diseases and as PM is a widespread pollutant relevant to the large majority of the human population and obesity a rising risk factor, our results, if confirmed in a larger population, might represent an important contribution towards the development of more targeted public health strategies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 EPIGET LAB, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
2 Department of Obstetrics and Gynecology ‘L. Mangiagalli’, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
3 Center of Excellence for Toxicological Research, Department of Medicine and Surgery, University of Parma, Italy
4 EPIGET LAB, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy; Department of Preventive Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy





